DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Windecker S, Tijssen J, Giustino G. , et al.
Trial design: rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: rationale and design of the GALILEO study.
Am Heart J 2017;
184: 81-87
We do not assume any responsibility for the contents of the web pages of other providers.